Friday, March 8, 2019
Home »
» Medical News Today: The FDA approve esketamine nasal spray for severe depression
Medical News Today: The FDA approve esketamine nasal spray for severe depression
Federal regulators have approved the use of the new prescription nasal spray drug esketamine for depression that has not responded to other treatments.
Related Posts:
How to socialize in a pandemicIn early March, when most Americans began social distancing, the hope was that life would get back to normal after just a few weeks. It’s become clear now that some distancing will be needed for many more months, or even year… Read More
Coronavirus cases continue to rise in Kentucky; governor touches on many topics: testing, politics, schools, health disparities, etc. State map, labeled by Kentucky Health News, shows rates through June 3. Click on it to enlarge. As news develops about the coronavirus and its covid-19 disease, this item may be updated. Official state guidance is a… Read More
Ky. coronavirus cases still up, with 289 reported Friday; another health-care worker has died of covid-19; how do we safely hug? Daily cases went down, but the two-week trendline angled farther upward. (Ky. Health News chart) As news develops about the coronavirus and its covid-19 disease, this item may be updated. Official state guidance is … Read More
Upward trend accelerates as Beshear announces 319 new virus cases, most in more than a month, with 65% in Jefferson County Kentucky Health News chart shows cases reported each day for the last month. Click on it to enlarge. By Melissa Patrick Kentucky Health News Gov. Andy Beshear announced 319 new cases of the coronavirus on Saturday,… Read More
Allison Adams, longtime public-health official, is new vice president for public policy at Foundation for a Healthy Kentucky Allison Adams Allison Adams, a longtime Maysville-area public-health official, will join the Foundation for a Healthy Kentucky as vice-president for public policy on June 15. She will replace Veronica Cecil, who wa… Read More
0 comments:
Post a Comment